Drugs / Omega 3 fatty acid
Omega 3 fatty acid
also known as
omega 3 fatty acids · fish oil · MyoRx Cream · Omega 3 Treasure · omega-3 · omega-3-fattyacid (Omacor) · ω-3 FA
Trials 16
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00690625 | Apr → Jul 2008 | myofascial pain syndrome | University of Washington | Completed | No outcome recorded |
| Phase 26 trials · 1 missed | ||||||
| Phase 2 | NCT04907864 | Jan 2020 → Mar 2022 | biliary tract cancer, colorectal cancer, gastric cancer, lung cancer +1 | Kil Yeon Lee | Unknown | No outcome recorded |
| Phase 2 | NCT04030065 | Dec 2018 → Nov 2019 | — | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
| Phase 2 | NCT02990091 | Jan 2017 → Jan 2023 | traumatic brain injury | University of Pennsylvania | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT01869764 | Nov 2013 → Jul 2018 | ductal breast carcinoma in situ, lobular breast carcinoma in situ, male breast carcinoma | Wake Forest University Health Sciences | Completed | No outcome recorded |
| Phase 2 | NCT00526357 | Aug 2007 → Feb 2009 | asthma | Firestone Institute for Respiratory Health | Completed | Missed primary |
| Phase 2 | NCT00408304 | Dec 2006 → Dec 2007 | chronic hepatitis C virus infection | Bnai Zion Medical Center | Unknown | No outcome recorded |
| Phase 33 trials · 1 missed | ||||||
| Phase 3 | NCT04836052 | Dec 2020 → Aug 2021 | COVID-19 | Hamad Medical Corporation | Unknown | No outcome recorded |
| Phase 3 | NCT04181593 | Nov 2019 → Feb 2021 | dry eye syndrome | OmegaD LLC | Completed | No outcome recorded |
| Phase 3 | NCT03167307 | Apr 2017 → Mar 2022 | depressive disorder | Gregor Berger | Completed | Missed primary |
| Phase 43 trials · 1 met primary | ||||||
| Phase 4 | NCT05529576 | Aug 2022 → Dec 2023 | bipolar disorder, major depressive disorder | Shanghai Mental Health Center | Unknown | No outcome recorded |
| Phase 4 | NCT03120299 | May 2017 → Mar 2021 | hypertriglyceridemia, type 2 diabetes mellitus | Shanghai Jiao Tong University School of Medicine | Completed | Met primary |
| Phase 4 | NCT02204410 | Jul 2014 → May 2016 | attention deficit-hyperactivity disorder | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT03006016 | Apr 2017 → Mar 2020 | morbid obesity | Centre Hospitalier Universitaire de Nice | Completed | No outcome recorded |
| — | NCT02552758 | May 2015 → Dec 2016 | schizophrenia | Shanghai Mental Health Center | Unknown | No outcome recorded |
| — | NCT02070042 | Feb 2014 → Sep 2015 | overactive bladder | TriHealth Inc. | Terminated | No outcome recorded |
| Comparator or background therapy11 trials | ||||||
| Phase 1/2 | NCT03406897 Comparator | Jul 2018 → Jul 2024 | hypoglycemia, type 1 diabetes mellitus | Rodolfo Alejandro | Completed | No outcome recorded |
| Phase 2 | NCT06125782 Comparator | Sep 2023 → Jan 2024 | autism spectrum disorder | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Completed | No outcome recorded |
| Phase 2 | NCT01248130 Comparator | Nov 2009 → Apr 2013 | autism spectrum disorder | Massachusetts General Hospital | Terminated | No outcome recorded |
| Phase 2/3 | NCT05005806 Comparator | Sep 2021 → Feb 2023 | Sjogren syndrome | Hawler Medical University | Completed | No outcome recorded |
| Phase 3 | NCT01633177 Comparator | Nov 2011 → May 2024 | type 2 diabetes mellitus | Brigham and Women's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04694027 Comparator | Jan → Mar 2021 | breast fibrocystic disease | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT01997853 Comparator | Jul 2012 → Aug 2013 | chronic periodontitis | Tatyasaheb Kore Dental College | Completed | No outcome recorded |
| — | NCT06190132 Comparator | Apr → Jul 2023 | — | Ain Shams University | Completed | No outcome recorded |
| — | NCT00644423 Comparator | Sep 2008 → Jul 2010 | post-traumatic stress disorder | Durham VA Medical Center | Completed | No outcome recorded |
| — | NCT00760786 Comparator | Jul 2008 → Feb 2010 | acute coronary syndrome | Samsung Medical Center | Unknown | No outcome recorded |
| — | NCT00579436 Comparator | Jan 2007 → Mar 2013 | metabolic syndrome X | Philip Kern | Completed | No outcome recorded |
Press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2019-06-15 | Zydus Lifesciences Limited | USFDA for Omega-3-Acid Ethyl Esters Capsules zyduslife.com ↗ |
| 2014-10-27 | Otsuka Pharmaceutical Development & Commercialization, Inc. | New product for Japanese women Nature Made Fish Oil Pearl Small Pearl-shaped Capsules Concentrated With Essential Nutritional Balance of Fish Oil otsuka.co.jp ↗ |
| 2010-11-14 | GlaxoSmithKline | New study findings show no benefit of prescription omega-3 fatty acids in prevention of recurrent symptomatic atrial fibrillation in affected patients gsk.com ↗ |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 29 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omega 3 fatty acid | “MIC includes ibuprofen, omega-3-fatty acid, oral nutritional supplement” PMID 35410294 ↗ Apr 2022 |
| Known as | fish oil | “Fish oil (FO), a mixture of omega-3 fatty acids mainly comprising docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), has been recommended for patients with type 2...” PMID 39163858 ↗ Aug 2024 |
| Known as | MyoRx Cream | “MyoRx Cream (6% Omega 3 Fatty Acid)” NCT00690625 ↗ |
| Known as | omega 3 fatty acids | “Omega-3 fatty acids are found in food such as fish and flaxseed as well as in dietary supplements labeled omega-3-oil.” NCT04836052 ↗1“The Effect of Omega-3 Fatty Acids Versus Gabapentin in Uremic Pruritus in Hemodialysis Patients” NCT06190132 ↗ |
| Known as | Omega 3 Treasure | “Omega-3 fatty acids capsules, 1 gram gel capsule, 2 capsules orally administered twice a day for 12 weeks Other Names: Omega-3 Fatty Acid fish oil Omega 3 Treasure” NCT03120299 ↗ |
| Known as | omega-3 | “the polyunsaturated fatty acids omega-3 (ω-3 FA) have been associated with several illnesses such as cancer, cardiovascular disease and autoimmune diseases” NCT05005806 ↗ |
| Known as | omega-3-fattyacid (Omacor) | “omega-3-fattyacid (Omacor)” NCT04907864 ↗ |
| Known as | ω-3 FA | “the polyunsaturated fatty acids omega-3 (ω-3 FA) have been associated with several illnesses such as cancer, cardiovascular disease and autoimmune diseases” NCT05005806 ↗ |
| Action | Activate | “there is evidence that fish oils also activate PPAR .” NCT00579436 ↗ |
| Modality | Other / unclassified | “Fish oil (FO), a mixture of omega-3 fatty acids mainly comprising docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)” PMID 39163858 ↗ Aug 2024 |
| Route | Oral | “3 weeks of orally administered fish oil supplements” NCT00526357 ↗ |